메뉴 건너뛰기




Volumn 8, Issue 2, 2006, Pages

Webcast video editorials - The $1.6 trillion question: If we're spending so much on healthcare, why so little improvement in quality?

Author keywords

[No Author keywords available]

Indexed keywords

ANTILIPEMIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

EID: 39049177820     PISSN: 15310132     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial
Times cited : (10)

References (4)
  • 1
    • 33744483140 scopus 로고    scopus 로고
    • Agency for Healthcare Research and Quality
    • The 2005 National Healthcare Quality report. January 9, Available at: www.qualitytools.ahrq.gov Accessed May 16, 2006
    • The 2005 National Healthcare Quality report. Agency for Healthcare Research and Quality. January 9, 2006. Available at: www.qualitytools.ahrq.gov Accessed May 16, 2006.
    • (2006)
  • 2
    • 33744486372 scopus 로고    scopus 로고
    • Record share of economy spent on health care
    • January 10, Available at: Accessed May 16, 2006
    • Kaufman M, Stein R. Record share of economy spent on health care. Washington Post. January 10, 2006: A01. Available at: http://www.washingtonpost.com/wp-dyn/content/article/2006/01/09/ AR2006010901932.html Accessed May 16, 2006.
    • (2006) Washington Post
    • Kaufman, M.1    Stein, R.2
  • 3
    • 25144518364 scopus 로고    scopus 로고
    • Financial anatomy of biomedical research
    • Available at: Accessed May 16, 2006
    • Moses H III, Dorsey ER, Matheson DHM, Thier SO. Financial anatomy of biomedical research. JAMA. 2005;294:1333-1342. Available at: http://jama.ama-assn.org/cgi/content/abstract/294/11/1333 Accessed May 16, 2006.
    • (2005) JAMA , vol.294 , pp. 1333-1342
    • Moses III, H.1    Dorsey, E.R.2    Matheson, D.H.M.3    Thier, S.O.4
  • 4
    • 31544471161 scopus 로고    scopus 로고
    • The break-even point: When medical advances are less important than improving the fidelity with which they are delivered
    • Available at: Accessed May 16, 2006
    • Woolf S, Johnson R. The break-even point: when medical advances are less important than improving the fidelity with which they are delivered. Ann Fam Med. 2005;3:545-552. Available at: http://www.annfammed.org/cgi/ content/abstract/3/6/545 Accessed May 16, 2006.
    • (2005) Ann Fam Med , vol.3 , pp. 545-552
    • Woolf, S.1    Johnson, R.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.